The data used in this study have been curated from
multiple publicly available data sources for hypertensive patients, including
the FDA’s Adverse Event Reporting System (FAERS), which houses all ADEs reported to the FDA by
pharmaceutical companies, healthcare providers, and consumers. The data,
including the hypertension dataset, is updated quarterly by the FDA and
currently includes reports submitted from the first quarter of 2004 to the last
quarter of 2019. This dataset focuses on drugs and their ADEs but includes additional
data such as disease, drug, and demographic information as well as information
related to patient outcome.